RTTNews | May 11, 2021 07:05AM EDT

07:04 Tuesday, May 11, 2021 (RTTNews) - Alnylam Pharma Begins Clinical Study Of Biannual Dosing Regimen Of Vutrisiran For Transthyretin-mediated Amyloidosis

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved